Predict your next investment

HEALTHCARE | Medical Equipment & Supplies
swereco.com

See what CB Insights has to offer

Stage

Acquired | Acquired

Valuation

$0000 

About Swereco Group

Swereco Group markets OTC products mainly to pharmacies or directly to health care providers.

Swereco Group Headquarter Location

Barnhusgatan 4

Stockholm, 111 23,

Sweden

+468-444 38 20

Latest Swereco Group News

CapMan exits Swedish manufacturer of OTV products, Swereco Group

Oct 5, 2015

05/10/2015 · Sweden · Healthcare · CapMan Funds managed by CapMan have sold their holding in Swereco Group AB, a Swedish manufacturer of OTC products, to Karo Bio AB (publ). The transaction was completed on 1 October 2015. “We are pleased with our investment in Swereco. During our ownership, Swereco has completed several key acquisitions, brought new and interesting products and designs to the OTC market and expanded sales to the other Nordic countries” comments Johan Bennarsten, responsible for the CapMan Life Science IV fund. Funds managed by CapMan, including the CapMan Life Science IV fund, invested in Swereco AB in 2010 and owned 35.75% of the company’s equity prior to the transaction. CapMan Plc is a significant investor in the CapMan Life Science IV fund. CapMan www.capman.com CapMan is one of the European leaders in the private equity industry. For more than 25 years, we have been developing companies and real estate and supporting their sustainable growth. We are committed to understanding the needs of our customers in an ever-changing market environment. Our objective is to provide attractive returns and innovative solutions for our investors and value adding services for professional investment partnerships, growth-oriented companies and tenants. Our entrepreneurial investment partnerships – Buyout, Real Estate, Russia and Credit – as well as our associated company Norvestia are responsible for investment activities and value creation. CapMan’s service business offering includes fundraising advisory services, purchasing activities and fund management services to both internal and external customers. CapMan has 100 private equity professionals and assets under management of €3.0 billion. Swereco Group AB www.swerecogroup.com Founded in 1973, Swereco develops and produces a range of products towards pharmacies and OTC market. Swereco recorded net sales of approx. €16.5 million in 2014. The company’s head office is in Stockholm with sales offices in Oslo and Copenhagen. Its products are also distributed in Finland, Germany, the UK and central Europe. Karo Bio AB www.karobio.se Karo Bio is a pharmaceutical company that develop drugs for key medical needs and with the aim to create a balance between preclinical projects and products and projects closer to the market. The headquarters are based in Huddinge and the share is listed on Nasdaq Stockholm.  

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Swereco Group

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Swereco Group is included in 1 Expert Collection, including Pharma Supply Chain.

P

Pharma Supply Chain

1,258 items

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.